Caren Deardorf - Chief Commercial Officer at Dianthus Therapeutics, Inc. /DE/

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
DNTH on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Caren Deardorf since 10/4/2023

Holdings reported by Caren Deardorf for Dianthus Therapeutics, Inc. /DE/

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 19.8K $237K $12.00 Nov 30, 2022 Direct
Stock Option (Right to Buy) 75K Aug 1, 2022 Direct Common Stock

Transactions reported by Caren Deardorf for Dianthus Therapeutics, Inc. /DE/

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.